A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil-Reference-Cited by-同舟云学术

A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil

Published:2001-09 Issue:6 Volume:85 Page:827-830
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Iacopetta B,Grieu F,Joseph D,Elsaleh H

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Reference19 articles.

1. Comparative Efficacy of Adjuvant Chemotherapy in Patients With Dukes' B Versus Dukes' C Colon Cancer: Results From Four National Surgical Adjuvant Breast and Bowel Project Adjuvant Studies (C-01, C-02, C-03, and C-04)

2. A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil

3. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer

4. Functional Analysis and DNA Polymorphism of the Tandemly Repeated Sequences in the 5'-terminal Regulatory Region of the Human Gene for Thymidylate Synthase.

Cited by 217 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Pathophysiology and Treatment of Prostate Cancer: Future Perspective;Handbook of Oncobiology: From Basic to Clinical Sciences;2024

2. Emerging Pathophysiology and Treatment of Prostate Cancer: Future Perspective;Handbook of Oncobiology: From Basic to Clinical Sciences;2023

3. Thymidylate synthase locus LOH in combination with genotype has prognostic and predictive significance in colorectal cancer;Molecular and Clinical Oncology;2021-09-17

4. One-carbon metabolism and global DNA methylation in mothers of individuals with Down syndrome;Human Cell;2021-08-19

5. Prediction of exposure-driven myelotoxicity of continuous infusion 5-fluorouracil by a semi-physiological pharmacokinetic–pharmacodynamic model in gastrointestinal cancer patients;Cancer Chemotherapy and Pharmacology;2020-03-09